Regulus Therapeutics (RGLS) Free Cash Flow (2012 - 2025)
Regulus Therapeutics (RGLS) free cash flow from Dec 31, 2012 to Mar 31, 2025. The TTM Regulus Therapeutics (RGLS) free cash flow is -$44M. You can adjust inflation or export chart.
Annual Free Cash Flow
Quarterly Free Cash Flow
Regulus Therapeutics (RGLS) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +54.62% |
| 3 Years TTM | +20.27% |
| 5 Years TTM | +15.27% |
| 10 Years TTM | +0.14% |
| All Time TTM | +3.66% |
Annual Free Cash Flow change of Regulus Therapeutics (RGLS)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$11M | -74.74% |
| 2024 | -$42M | +53.43% |
| 2023 | -$27M | +5.76% |
| 2022 | -$26M | +6.19% |
| 2021 | -$24M | +94.42% |
| 2020 | -$13M | -37.43% |
| 2019 | -$20M | -53.71% |
| 2018 | -$43M | -26.71% |
| 2017 | -$59M | +2.21% |
| 2016 | -$58M | +12.83% |
| 2015 | -$51M | +25.97% |
| 2014 | -$41M | +39.58% |
| 2013 | -$29M | +195.14% |
| 2012 | -$9.87M | N/A |